Back to Results
First PageMeta Content
Dopamine agonist / Organochlorides / Medicine / Chemistry / Atypical antipsychotics / Pharmacology / Apomorphine / Catechols / Sexual orientation and medicine


FDA Approved Labeling Text for NDA[removed]Dated[removed]mg/mL For Subcutaneous Use Only
Add to Reading List

Document Date: 2010-09-07 12:18:07


Open Document

File Size: 249,24 KB

Share Result on Facebook

Currency

pence / /

IndustryTerm

sterile solution / treatment for Parkinson’s disease / /

MedicalCondition

loss of consciousness / tremor / Syncope / Vomiting / Parkinson’s disease / disease / pulmonary embolism / hypersensitivity / thrombus / idiopathic Parkinson’s disease / patients’ Parkinson’s disease / bradykinesia / postural instability / advanced Parkinson’s disease / Nausea / profound hypotension / severe nausea / /

Organization

Intravenous Administration / DOSAGE AND ADMINISTRATION / FDA / PRECAUTIONS / /

Product

granisetron / APOKYN / Rx / ondansetron / /

Technology

crystallization / Pharmacokinetics / /

SocialTag